{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-023404","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.267473+00:00","generated_at":"2026-05-15T21:46:03.678844+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Vicarious Surgical receives NYSE delisting notice; trading suspended, moves to OTCID","bullets":["NYSE notified Vicarious Surgical on Mar 3, 2026 of delisting for falling below $15M avg mkt cap over 30 trading days.","Trading suspended after market close Mar 3, 2026; company evaluating whether to appeal within 10 business days.","Common stock expected to commence quotation on OTCID tier on Mar 4, 2026 under symbol RBOT.","Delisting may reduce liquidity, market price, and ability to raise equity financing.","OTC markets significantly more limited than NYSE; company provides no assurance of continued trading."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-023404","json":"https://secwatch.observer/filing/0001213900-26-023404.json","markdown":"https://secwatch.observer/filing/0001213900-26-023404.md","text":"https://secwatch.observer/filing/0001213900-26-023404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/ea0279907-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:46:03.678844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"201d6fc96307bc0598e7bfef97be683d468a2407","claim":"Vicarious Surgical Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).","evidence_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”) notified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s common stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings to delist the Commo","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001493152-26-025277","ticker":"VSTD","company_name":"Vestand Inc.","filed_at":"2026-05-26T21:18:59+00:00","headline":"Vestand receives Nasdaq delisting notice for late quarterly and annual filings","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025277","json":"https://secwatch.observer/filing/0001493152-26-025277.json","markdown":"https://secwatch.observer/filing/0001493152-26-025277.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226025277/0001493152-26-025277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226025277/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"May 19, 2026, the Company received a Staff Delisting Determination letter (the “Staff Determination”) from Nasdaq notifying\nit that Nasdaq has initiated a process which could result in the delisting of the Company’s secu","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226025277/0001493152-26-025277-index.htm"}},{"accession":"0001213900-26-054565","ticker":"AGAE","company_name":"Allied Gaming & Entertainment Inc.","filed_at":"2026-05-11T21:09:36+00:00","headline":"AGAE receives Nasdaq delisting notice over bid price <$1.00 and late 10-K; will appeal","event_type":"regulatory","sec_items":["3.01","5.03","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054565","json":"https://secwatch.observer/filing/0001213900-26-054565.json","markdown":"https://secwatch.observer/filing/0001213900-26-054565.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708341/000121390026054565/0001213900-26-054565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708341/000121390026054565/ea0290063-8k_allied.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"termination\nbefore an independent Hearings Panel (the “Panel”) by May 13, 2026. On November 4, 2025, Staff notified the Company\nthat the bid price of the Common Stock had closed at less than $1.00 per share over 30 consecutive business days, and, as a result, did\nnot comply with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Staff Determination was issued pursuant\nto Nasdaq Listing Rule 5810(c)(3)(A) on the grounds that the Company has not regained compliance with the Minimum Bid Price Rule during\na 180-day compliance period and is not eligible for a second 180-day complian","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1708341/000121390026054565/0001213900-26-054565-index.htm"}},{"accession":"0001731122-26-000668","ticker":"SBEV","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M","event_type":"regulatory","sec_items":["1.01","1.02","3.01","3.02","5.03","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000668","json":"https://secwatch.observer/filing/0001731122-26-000668.json","markdown":"https://secwatch.observer/filing/0001731122-26-000668.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/0001731122-26-000668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/e7604_8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"April 29, 2026, the Company received notice from NYSE Regulation (the “NYSE”)\nthat the Company is not in compliance with the shareholders’ equity requirement of $6 million as of December 31, 2025 as outlined\nin Section 1","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/0001731122-26-000668-index.htm"}},{"accession":"0001493152-26-019609","ticker":"VSTD","company_name":"Vestand Inc.","filed_at":"2026-04-29T23:59:59+00:00","headline":"Vestand receives Nasdaq delisting notice for late 10-K filing; may submit compliance plan by May 18, 2026","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-019609","json":"https://secwatch.observer/filing/0001493152-26-019609.json","markdown":"https://secwatch.observer/filing/0001493152-26-019609.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226019609/0001493152-26-019609-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226019609/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"April 23, 2026, Vestand Inc. (the “Company”) received a staff deficiency notice (the “Notice”) from The Nasdaq\nStock Market (“Nasdaq”) indicating that, because Nasdaq has not yet received the Company’s Form 10-K for the","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226019609/0001493152-26-019609-index.htm"}},{"accession":"0001654954-26-005548","ticker":"ONFO","company_name":"Onfolio Holdings, Inc","filed_at":"2026-05-29T20:30:53+00:00","headline":"Onfolio receives Nasdaq delisting notice for insufficient equity ($1.22M vs $2.5M min)","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-005548","json":"https://secwatch.observer/filing/0001654954-26-005548.json","markdown":"https://secwatch.observer/filing/0001654954-26-005548.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426005548/0001654954-26-005548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426005548/onfo_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"May 26, 2026, Onfolio Holdings Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) informing the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice states that the Company’s Quarterly Report on Form 10-Q for the for the period ended March 31, 2026 reported stockholders’ equity of $1,216,603. As of the date of the Notice","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426005548/0001654954-26-005548-index.htm"}},{"accession":"0001493152-26-025433","ticker":"SONM","company_name":"DNA X, Inc.","filed_at":"2026-05-27T20:35:28+00:00","headline":"DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider","event_type":"regulatory","sec_items":["1.01","2.03","3.01","3.02","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025433","json":"https://secwatch.observer/filing/0001493152-26-025433.json","markdown":"https://secwatch.observer/filing/0001493152-26-025433.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests\na hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm"}},{"accession":"0001493152-26-025244","ticker":"XHLD","company_name":"TEN Holdings, Inc.","filed_at":"2026-05-26T20:05:22+00:00","headline":"TEN Holdings receives Nasdaq equity deficiency notice; issues 500k shares for $500k","event_type":"regulatory","sec_items":["1.01","3.01","3.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025244","json":"https://secwatch.observer/filing/0001493152-26-025244.json","markdown":"https://secwatch.observer/filing/0001493152-26-025244.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030954/000149315226025244/0001493152-26-025244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030954/000149315226025244/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"May 26, 2026, the Company received a deficiency letter from the Listing Qualifications Department (the “ Staff ”)\nof The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasda","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2030954/000149315226025244/0001493152-26-025244-index.htm"}},{"accession":"0001140361-26-022598","ticker":"DEVS","company_name":"DevvStream Corp.","filed_at":"2026-05-22T20:05:36+00:00","headline":"DevvStream receives Nasdaq notice of failure to regain net income compliance; delisting risk elevated","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-022598","json":"https://secwatch.observer/filing/0001140361-26-022598.json","markdown":"https://secwatch.observer/filing/0001140361-26-022598.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854480/000114036126022598/0001140361-26-022598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854480/000114036126022598/ef20074443_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 3, 2026, the New York Stock Exchange (the “NYSE”)\nnotified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s\ncommon stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the\nNYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive\n30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings\nto delist the Commo","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026023404/0001213900-26-023404-index.htm","comparable_excerpt":"April 7, 2026, the Company received a separate written notification (the “ Bid Price\n Notice ”) from Nasdaq indicating that because the bid price for the Company’s common shares, no par value (“ Common Shares ”), for the","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1854480/000114036126022598/0001140361-26-022598-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}